Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shungo Miyamoto is active.

Publication


Featured researches published by Shungo Miyamoto.


Surgery Today | 2001

Ruptured Aneurysm of the Visceral Artery: Report of Two Cases

Shigetoshi Matsuo; Satoshi Yamaguchi; Shungo Miyamoto; Tatsuhiro Ishii; Noritsugu Tsuneoka; Shiro Obata; Tomayoshi Hayashi; Takashi Kanematsu

Abstract We present herein two cases of a ruptured aneurysm of the visceral artery. The first case involved a 74-year-old man with abdominal pain who was admitted to our hospital with a tentative diagnosis of intra-abdominal bleeding of unknown origin. Computed tomography revealed a hematoma in the greater curvature of the stomach. At surgery, a hematoma along the right gastroepiploic artery was found and totally removed. Histological examination showed a pseudoaneurysm of unknown etiology. The second case involved a 68-year-old man with progressive anemia who presented with spontaneous intra-abdominal bleeding. A ruptured aneurysm of the accessory middle colic artery was diagnosed by superior mesenteric angiography. The ruptured aneurysm was ligated and totally resected without a colectomy. Histological examination showed a pseudoaneurysm of unknown etiology. The postoperative courses were uneventful, and both patients were doing well at the time of writing.


Cell Transplantation | 2002

Role of intrasplenic hepatocyte transplantation in improving survival and liver regeneration after hepatic resection in cirrhotic rats.

Tarik A. Ahmad; Susumu Eguchi; Katsuhiko Yanaga; Shungo Miyamoto; Yukio Kamohara; Hikaru Fujioka; Junichiro Furui; Takashi Kanematsu

We studied the effect of preoperative hepatocyte transplantation on the prevention of liver failure in cirrhotic rats after hepatic resection. Two groups of Lewis rats were rendered cirrhotic by IP injection of 1% dimethylnitrosamine and were subjected to 33% hepatectomy. Two days before the resection, 36 rats in group I received intrasplenic hepatocyte transplantation, and 25 rats in group II were given intrasplenic injection of normal saline as a control. By the end of the third postoperative day, the rats in group I had better survival and a better biochemical profile than those in group II. The liver growth rate and the labeling index of proliferating cell nuclear antigen (PCNA-LI) showed a steady rise in group I. Compared with group II, group I had a significantly lower transforming growth factor (TGF-β1) level (p < 0.05). We conclude that preoperative intrasplenic hepatocyte transplantation improves survival and facilitates regeneration in cirrhotic rats after hepatic resection.


Hepatology Research | 2002

Hepatic expression and serum levels of thrombomodulin reflect the extent of liver injury in rats with fulminant hepatic failure and extensive hepatectomy

Shungo Miyamoto; Susumu Eguchi; Nozomu Sugiyama; Yasushi Kawazoe; Yukio Kamohara; Hikaru Fujioka; Katsuhiko Yanaga; Junichiro Furui; Takashi Kanematsu

In order to evaluate the biological significance of thrombomodulin (TM) in the serum and its expression in the liver, changes in TM were investigated in rats with fulminant hepatic failure (FHF) or after extensive hepatectomy. Forty-two rats were divided into four groups as follows: control (sham, n=6), 70% hepatectomy (70% Hx, n=12), 90% hepatectomy (90% Hx, n=12) and fulminant hepatic failure (FHF, n=12). The soluble-TM levels in the 90% Hx and FHF groups were significantly higher than that in the 70% Hx group. In the FHF group, the soluble-TM level 24 h after induction was significantly higher than that at 12 h (P<0.05). Moreover, the level of soluble TM was significantly higher in the FHF group than that in the 90% Hx group, while hyaluronic acid was not increased at statistical significance. The expression of TM in the liver intensified with time in both FHF and 90% Hx groups, which was more pronounced in zone 3 of the liver in FHF group than in the 90% Hx group. In conclusion, elevation of s-TM in the serum and expression of TM in the sinusoidal endothelial cell are useful markers of hepatic failure and its sinusoidal endothelial injury, especially in the state of FHF, since the presence of necrotic liver tissue is the only difference between FHF and 90% Hx in the model of the rats.


Transplantation | 2003

Changes in serum levels of hepatocyte growth factor in patients undergoing adult-to-adult living-donor liver transplantation.

Susumu Eguchi; Katsuhiko Yanaga; Sadayuki Okudaira; Nozomu Sugiyama; Shungo Miyamoto; Junichiro Furui; Takashi Kanematsu

Changes in the serum concentration of hepatocyte growth factor (HGF), a potent mitogen for hepatocytes, were investigated in adult-to-adult living-donor liver transplantation (LDLT) in which liver regeneration is involved. Between August 2000 and November 2002, 15 consecutive adult-to-adult LDLTs were performed using the right lobe graft. The recipients were divided into two groups: acute liver failure (n=6) and chronic liver failure (n=9). In addition, right lobe donors (n=12) were evaluated. Measurement of HGF was performed on preoperative and postoperative days 1, 3, 7, and 14 after LDLT. The pretransplant levels of serum HGF were higher in the acute liver failure group than in the chronic liver failure group (P<0.05). After liver replacement, serum HGF levels normalized rapidly in both groups and remained rather low. Despite vigorous liver regeneration in all groups, serum HGF levels did not change significantly after adult-to-adult LDLT with right lobe graft.


Transplantation Proceedings | 1999

Efficacy and current problems with a porcine hepatocyte-based bioartificial liver: light and shade.

Susumu Eguchi; Yukio Kamohara; Nozomu Sugiyama; Yasushi Kawazoe; H Tamura; M Morishita; Shungo Miyamoto; Takashi Azuma; Hikaru Fujioka; Junichiro Furui; Takashi Kanematsu


World Journal of Gastroenterology | 2008

Metabolism for cyclosporin A during liver regeneration after partial hepatectomy in rats

Shigeki Nagayoshi; Susumu Eguchi; Yukio Kamohara; Mitsuhisa Takatsuki; Shungo Miyamoto; Satoshi Mochizuki; Akihiko Soyama; Hirotaka Tokai; Masaaki Hidaka; Yoshitsugu Tajima; Takashi Kanematsu


Surgery | 2007

A modified triangular venoplasty for reconstruction of middle hepatic vein tributaries in living donor liver transplantation

Susumu Eguchi; Mitsuhisa Takatsuki; Akihiko Soyama; Masaaki Hidaka; Hirotaka Tokai; Koji Hamasaki; Kensuke Miyazaki; Shungo Miyamoto; Yoshitsugu Tajima; Takashi Kanematsu


American Journal of Surgery | 2006

Simplified technique for middle hepatic vein tributary reconstruction of a right hepatic graft in adult living donor liver transplantation

Mitsuhisa Takatsuki; Shungo Miyamoto; Yukio Kamohara; Yoshitsugu Tajima; Takashi Kanematsu


Hepato-gastroenterology | 2000

Intraportal administration of low-dose recombinant human hepatocyte growth factor enhances effects of hepatocellular transplantation.

Nozomu Sugiyama; Susumu Eguchi; Yasushi Kawazoe; Shungo Miyamoto; Yukio Kamohara; Hikaru Fujioka; Junichiro Furui; Maki Sato; Takehisa Ishii; Takashi Kanematsu


Transplantation | 2004

Immunodynamics of basiliximab in liver allograft recipient under continuous hemodiafiltration.

Susumu Eguchi; Katsuhiko Yanaga; Sadayuki Okudaira; Shungo Miyamoto; Yuichiro Itoh; Hiroyuki Inuo; Kohsho Yamanouchi; Takayuki Hamada; Junichiro Furui; Takashi Kanematsu

Collaboration


Dive into the Shungo Miyamoto's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge